Understanding the inhibitory effect of highly potent and selective archazolides binding to the vacuolar ATPase

Vacuolar ATPases are a potential therapeutic target because of their involvement in a variety of severe diseases such as osteoporosis or cancer. Archazolide A (1) and related analogs have been previously identified as selective inhibitors of V-ATPases with potency down to the subnanomolar range. Here...

Full description

Saved in:
Bibliographic Details
Main Authors: Dreisigacker, Sandra (Author) , Menche, Dirk (Author)
Format: Article (Journal)
Language:English
Published: 27 August 2012
In: Journal of chemical information and modeling
Year: 2012, Volume: 52, Issue: 8, Pages: 2265-2272
ISSN:1549-960X
DOI:10.1021/ci300242d
Online Access:Verlag, Volltext: http://dx.doi.org/10.1021/ci300242d
Verlag, Volltext: http://pubs.acs.org/doi/10.1021/ci300242d
Get full text
Author Notes:Sandra Dreisigacker, Dorota Latek, Svenja Bockelmann, Markus Huss, Helmut Wieczorek, Slawomir Filipek, Holger Gohlke, Dirk Menche, Teresa Carlomagno
Description
Summary:Vacuolar ATPases are a potential therapeutic target because of their involvement in a variety of severe diseases such as osteoporosis or cancer. Archazolide A (1) and related analogs have been previously identified as selective inhibitors of V-ATPases with potency down to the subnanomolar range. Herein we report on the determination of the ligand binding mode by a combination of molecular docking, molecular dynamics simulations, and biochemical experiments, resulting in a sound model for the inhibitory mechanism of this class of putative anticancer agents. The binding site of archazolides was confirmed to be located in the equatorial region of the membrane-embedded VO-rotor, as recently proposed on the basis of site-directed mutagenesis. Quantification of the bioactivity of a series of archazolide derivatives, together with the docking-derived binding mode of archazolides to the V-ATPase, revealed favorable ligand profiles, which can guide the development of a simplified archazolide analog with potential therapeutic relevance.
Item Description:Gesehen am 29.11.2018
Physical Description:Online Resource
ISSN:1549-960X
DOI:10.1021/ci300242d